Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones
about
Survivors Remorse: antibody-mediated protection against HIV-1.Rev-RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates.Lessons from acute HIV infection.Molecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection eventsDevelopment of a contemporary globally diverse HIV viral panel by the EQAPOL programParticle infectivity of HIV-1 full-length genome infectious molecular clones in a subtype C heterosexual transmission pair following high fidelity amplification and unbiased cloningSynergy in monoclonal antibody neutralization of HIV-1 pseudoviruses and infectious molecular clones.Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.Creating an African HIV clinical research and prevention trials network: HIV prevalence, incidence and transmission.High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.GSK1265744 demonstrates robust in vitro activity against various clades of HIV-1.Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides.Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α ResistanceImmune evasion activities of accessory proteins Vpu, Nef and Vif are conserved in acute and chronic HIV-1 infection.Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection CohortPhase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized TrialConserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" processRole of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection.Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicidesHIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacityHIV-1 Vpu Mediates HLA-C Downregulation.Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaquesDerivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection.HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners.Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.Virus-Host Gene Interactions Define HIV-1 Disease Progression.An infectious molecular clone in early infection with HIV-1 subtype CRF01_AE strains: construction and biological properties.The HIV Genomic Incidence Assay Meets False Recency Rate and Mean Duration of Recency Infection Performance Standards.Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma.
P2860
Q30238730-A7576FA8-D681-4365-A21B-E50FA4C397C1Q30276860-41379B6B-6B58-4AD7-9C75-D3AE703DEDAEQ30490195-A07E727E-3443-4C00-8C5A-C01D4C16AE00Q33900353-2A478F12-E45B-4108-8B20-A3DCC1757072Q33922689-D467D008-82D6-4EA2-A9A5-96C1F46FF8C7Q34614272-A41967E5-F56B-4393-8714-9600CC7E458EQ34762224-2BEB6139-1298-4C76-BD44-14463FC15F4DQ34874985-325702A0-12AC-4B33-91E5-03E590473DD0Q34989509-EAAD1C33-C652-4232-9CAE-F6F32D1CBFDCQ35188022-6DBDB4CB-9165-43C9-8B35-95F1359BAAF0Q35216488-A2825347-3966-4B07-9F58-C629400A1DE6Q35629509-79432C74-5D67-41D5-8CEB-E4EE579FCEBFQ35748138-7D78A56F-1D78-4715-B4C9-8188F1FD992AQ35778333-C509F29A-FBB9-47BB-AD66-F62B815C26F5Q35855904-B3416E96-F3A6-44FC-8858-8827D1F2FC1BQ35894094-69C8B518-7F42-4DC6-BC0F-0CA4087AC1D3Q36166932-C58EDDB9-77B0-46A0-BB7A-C7109EDDE1A4Q36288959-1334902D-085B-4909-81D7-783C61F021EFQ36290832-2C7AA4A4-49DA-4AAC-8214-3F88685D7C42Q36785795-2F1E662C-74D0-4B95-8925-57303BD2FEF6Q36827382-FB3CE640-9938-4583-86AA-E142D3D2DD9EQ36997294-B061A81D-16D5-4434-8F00-E46D449B8F33Q37021717-491686C7-1DDD-40C9-8FE5-B1A83CB509A7Q37252894-11558017-ECF4-4B28-8DDF-23C955E7F717Q37444204-76EFBCF9-A054-4A9C-803C-75AB7A716D19Q37644079-43EEB32E-3F51-4774-8EF9-3E23F2E2A13DQ39400038-AD0AF9B1-8D13-41CF-B982-63D63318A21DQ39573789-13A859F7-0A4D-4CBC-942C-431C282A3F50Q40091554-F5C3ECE8-65D6-40A8-A6D8-BC111EED6CD4Q47146547-CB319721-3870-46E0-91C2-AB5194572CA4Q52577900-3797B057-AB4F-48AD-B7A0-8622E4221512
P2860
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Molecular identification, clon ...... /D infectious molecular clones
@ast
Molecular identification, clon ...... /D infectious molecular clones
@en
type
label
Molecular identification, clon ...... /D infectious molecular clones
@ast
Molecular identification, clon ...... /D infectious molecular clones
@en
prefLabel
Molecular identification, clon ...... /D infectious molecular clones
@ast
Molecular identification, clon ...... /D infectious molecular clones
@en
P2093
P2860
P50
P1433
P1476
Molecular identification, clon ...... /D infectious molecular clones
@en
P2093
Deogratius Ssemwanga
Emmanuel Cormier
Eric Hunter
Eugene Ruzagira
Gerald H Learn
Jill Gilmour
John C Kappes
Joshua Baalwa
Julie M Decker
P2860
P356
10.1016/J.VIROL.2012.10.009
P407
P50
P577
2012-11-01T00:00:00Z